Abstract | BACKGROUND: METHODS: The expressions of miR-500 and miR-628 in NSCLC tissues and cell lines were measured by quantitative real-time PCR (qRT-PCR). Cells migration, invasion, proliferation, adhesion and apoptosis abilities were test to analyze the biological functions of miR-500 and miR-628 in NSCLC. A bioinformatic analysis was conducted to predict the target genes regulated by miR-500 and miR-628 using TargetScan (http://www.targetscan.org/mamm/). Luciferase reporter assay was employed to validate the direct targeting of ING1 by miR-500 and miR-628. RESULTS: In this study, miR-500 and miR-628 were up-regulated with NSCLC tissues. Furthermore, inhibition of miR-500 and miR-628 significantly suppressed NSCLC cells proliferation, migration, invasion and adhesion, and induced NSCLC cells apoptosis. Additionally, the result showed that ING1 functioned as the direct target for miR-500 and miR-628, which was a core tumor suppressor in regulating NSCLC progression. Over-expression of ING1 could dramatically inhibit NSCLC cells proliferation, migration and invasion, and promote cells apoptosis. CONCLUSION: These results brought new insights into the oncogenic role of miR-500 and miR-628 in NSCLC, indicating that miR-500 and miR-628 might be the novel biomarkers for the diagnosis and prognosis of NSCLC.
|
Authors | Ming Jiang, Li-Yang Zhou, Nan Xu, Qing An |
Journal | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
(Biomed Pharmacother)
Vol. 108
Pg. 1628-1639
(Dec 2018)
ISSN: 1950-6007 [Electronic] France |
PMID | 30372865
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- ING1 protein, human
- Inhibitor of Growth Protein 1
- MIRN500 microRNA, human
- MIRN628 microRNA, human
- MicroRNAs
|
Topics |
- A549 Cells
- Carcinoma, Non-Small-Cell Lung
(metabolism, prevention & control)
- Cell Movement
(physiology)
- Cell Proliferation
(physiology)
- Down-Regulation
(physiology)
- Gene Targeting
(methods)
- Humans
- Inhibitor of Growth Protein 1
(antagonists & inhibitors, biosynthesis)
- Lung Neoplasms
(metabolism, prevention & control)
- MicroRNAs
(antagonists & inhibitors, metabolism)
|